Table 3. MC1R Arg151Cys polymorphism and PD risk.
| Genotype of Arg151Cys | ||||
|---|---|---|---|---|
| Arg/Arg | Arg/Cys | Cys/Cys | P-trend | |
| Case/control | 224/1015 | 42/160 | 6/10 | |
| Crude Relative risk | 1 (ref) | 1.19 (0.82,1.72) |
2.55 (0.91, 7.12) |
0.11 |
| Multivariate1 | 1(ref) | 1.23 (0.84,1.82) |
3.15 (1.06, 9.37) |
0.06 |
| Red hair 1 | P-interaction | |||
| No | 1(ref) | 1.25 (0.81, 1.92) |
-- | 0.23 |
| Yes | 0.67 (0.19, 2.32) |
0.95 (0.30, 2.97) |
4.93 (1.50, 16.2) |
|
Conditional logistic regressions were used to estimate relative risks.
Adjusted for smoking(never smoker, past smoker, or current smoker: cigarettes/d, 1-14 or ≥ 15), ethnicity (Caucasian, African-American, and Asian and others), BMI (<23, 23-24.9, 25-26.9, 27-29.9, or ≥30 kg/m2), use of non-steroid anti-inflammatory drug (yes/no), and intakes of alcohol(none, 1-4.9, 5-9.9, 10-14.9, or ≥15 g/d for women; none, 1-9.9, 10-19.9, 20-29.9, or ≥30 g/d for men), caffeine (quintiles), and lactose (quintiles).